MedDataX Logo

Diagnostic Pilot Study of Dual Energy Absorptiometry in the Detection of Osteopenia or Osteoporosis in Patients With Thalassemia Major

NCT ID: NCT00006138

Last Updated: 2005-06-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

35 participants

Study Classification

OBSERVATIONAL

Study Start Date

1998-06-30

Study Completion Date

2000-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

OBJECTIVES:

I. Determine the frequency and severity of osteopenia and osteoporosis in patients with thalassemia major who undergo dual energy x-ray absorptiometry, and correlate these findings with other relevant endocrinologic measurements.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

PROTOCOL OUTLINE:

Patients undergo dual energy x-ray absorptiometry for bone density measurements, height (sitting and standing) and weight measurements, comprehensive endocrinologic examination, and assessment of the severity of iron overload at baseline, and then at years 1 and 2.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Osteoporosis Thalassemia Major Osteopenia

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

disease-related problem/condition genetic diseases and dysmorphic syndromes hematologic disorders osteoporosis rare disease thalassemia major

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of thalassemia major with iron overload
* Not pregnant
* Negative pregnancy test
Minimum Eligible Age

6 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Children's Hospital of Philadelphia

OTHER

Sponsor Role collaborator

National Center for Research Resources (NCRR)

NIH

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Alan Richard Cohen

Role: STUDY_CHAIR

Children's Hospital of Philadelphia

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CHP-IRB-1998-6-1502

Identifier Type: -

Identifier Source: secondary_id

CHP-GCRC-1655

Identifier Type: -

Identifier Source: secondary_id

199/15314

Identifier Type: -

Identifier Source: org_study_id